18F-FDG
In production
Fluorodeoxyglucose
Whole body diagnostics
18F-FDG (fluorodeoxyglucose) is a glucose molecule in which one of the hydroxyl groups is replaced by the radioactive isotope fluorine-18.
Our body uses glucose for energy, so tumor cells consume more glucose than normal cells due to their active growth. This means that 18F-FDG molecules are concentrated in the place where glucose is actively consumed in particular tumor cells.
Fluorodeoxyglucose is versatile
1
It is absorbed by all cells, since its structure is close to ordinary glucose
2
Tumor cells accumulate the drug faster than healthy cells, so they are clearly visible on the scan
3
Excreted from the patient's body within 24 hours
Advantages of the tracer
Stability
The ability to deliver the tracer to remote diagnostic centers
Accuracy
Diagnostics using the tracer allows to get accurate results
Universality
You can examine almost the entire human body with the help of the tracer, excluded the brain, which is characterized by increased glucose consumption, and the genitourinary system
Other tracers
Expecting RF approval
18F-FET
18F-fluoroethyl-L-tyrosine, is actively
used in diagnosis in patients
with brain neoplasms.
More details about the pharmaceutical
used in diagnosis in patients
with brain neoplasms.
Expecting RF approval
18F-PSMA
18F-PSMA is a nuclide-containing
molecule-ligand of prostate-specific
membrane antigen, which is used in
the prostate tumors diagnostics.
More details about the pharmaceutical
molecule-ligand of prostate-specific
membrane antigen, which is used in
the prostate tumors diagnostics.
Find out how
we produce the tracer
Delivery to PET/CT medical locations
Our own production sites are located in Ufa, Yelets, Stavropol,
Novosibirsk and Pavlovskaya town in Krasnodar Region.
Partners' production sites are in Balashikha, Chelyabinsk, Kazan.
Pharmaceuticals are supplied daily to more than 35 diagnostic centers.
Balashikha
Yelets
Kazan
st. Pavlovskaya
Ufa
Stavropol
Chelyabinsk
Novosibirsk